Tumor angiogenesis of non-small cell lung cancer

被引:38
|
作者
Shijubo, N
Kojima, H
Nagata, M
Ohchi, T
Suzuki, A
Abe, S
Sato, N
机构
[1] Sapporo Med Univ, Sch Med, Dept Internal Med 3, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
[2] Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
关键词
VEGF; bFGF; PD-ECGF; chemokine; MMP; VE-cadherin; integrin; osteopontin; mast cells;
D O I
10.1002/jemt.10257
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Lung cancer is one of the commonest causes of cancer death in developed countries. Recent evidence suggests that angoigenesis is related to poor prognosis in many solid tumors including non-small cell lung cancer (NSCLC). Angiogenesis is regulated by a complex interaction among growth factors and cytokines and influenced by proteolytic enzymes such as plasminogen activators and matrix metalloproteases, expression of adhesion molecules, and distribution of extracellular matrices. Fibroblasts, macrophages, mast cells, and endothelial cells themselves also affect angiogenesis. This review concentrates on angiogenic growth factors including vascular endothelial growth factor, angiopoietins, platelet derived endothelial growth factor, and basic fibroblast growth factor, proteases, adhesion molecules including vascular endothelial cadherin and integrins, osteopontin, and mast cell products in tumor angiogenesis of NSCLC. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:186 / 198
页数:13
相关论文
共 50 条
  • [21] Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation
    Rivas-Fuentes, Selma
    Salgado-Aguayo, Alfonso
    Pertuz Belloso, Silvana
    Gorocica Rosete, Patricia
    Alvarado-Vasquez, Noe
    Aquino-Jarquin, Guillermo
    JOURNAL OF CANCER, 2015, 6 (10): : 938 - 952
  • [22] Prognostic value of angiogenesis in operable non-small cell lung cancer
    Giatromanolaki, A
    Koukourakis, M
    OByrne, K
    Fox, S
    Whitehouse, R
    Talbot, DC
    Harris, AL
    Gatter, KC
    JOURNAL OF PATHOLOGY, 1996, 179 (01): : 80 - 88
  • [23] The angiogenesis patterns as a prognostic factor in non-small cell lung cancer
    Giatromanolaki, A
    3RD INTERNATIONAL CONGRESS ON LUNG CANCER, 1998, : 53 - 57
  • [24] HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer
    Jackson, Autumn L.
    Zhou, Bing
    Kim, William Y.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (10) : 1047 - 1057
  • [25] Strategies targeting angiogenesis in advanced non-small cell lung cancer
    Wang, Jun
    Chen, Jianpeng
    Guo, Yan
    Wang, Baocheng
    Chu, Huili
    ONCOTARGET, 2017, 8 (32) : 53854 - 53872
  • [26] Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer
    Guangmei Mao
    Yan Liu
    Xi Fang
    Yahan Liu
    Li Fang
    Lianjun Lin
    Xinmin Liu
    Nanping Wang
    Angiogenesis, 2015, 18 : 373 - 382
  • [27] Angiogenesis in non-small cell lung cancer (NSCLC): Gender differences in tumor and circulating angiogenic factors
    Hanrahan, Emer O.
    Prudkin, Ludmila
    Lin, Heather Yan
    Behrens, Carmen
    Massarelli, Erminia
    Herynk, Matthew H.
    Du, Danny
    Wislez, Marie
    Kurie, Jonathan M.
    Herbst, Roy
    Lee, J. Jack
    Wistuba, Ignacio I.
    Heymach, John V.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3342S - 3343S
  • [28] Transcriptional repressor Snail promotes tumor growth and angiogenesis in human non-small cell lung cancer
    Yanagawa, Jane
    Walser, Tonya C.
    Lee, Jay M.
    Dohadwala, Mariam
    Zhu, Li X.
    Krysan, Kostyantyn
    Luo, Jie
    Sharma, Sherven
    Dubinett, Steven M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2008, 207 (03) : S47 - S47
  • [29] Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer
    Mao, Guangmei
    Liu, Yan
    Fang, Xi
    Liu, Yahan
    Fang, Li
    Lin, Lianjun
    Liu, Xinmin
    Wang, Nanping
    ANGIOGENESIS, 2015, 18 (03) : 373 - 382
  • [30] Tumor angiogenesis as an important prognostic factor in advanced non-small cell lung cancer (Stage IIIA)
    Bacic, Ivan
    Karlo, Robert
    Zadro, Ana Sostaric
    Zadro, Zvonko
    Skitarelic, Neven
    Antabak, Anko
    ONCOLOGY LETTERS, 2018, 15 (02) : 2335 - 2339